Latest News

Date Title Topic
25 Nov 2013 Immuno-Oncology 2013 Webcasts
21 Nov 2013 Continuation of Bevacizumab with Second-Line Chemotherapy after the Standard First-Line Bevacizumab-Containing Therapy in mCRC: What is the value of KRAS status? Gastrointestinal cancers
OncologyPRO
19 Nov 2013 ESMO Press Release: ESMO Spearheads International Collaboration to Assure Patient Access to Safe and Effective Cancer Medicines
28 Oct 2013 Castration Resistant Prostate Cancer; the Rise & Fall of Systemic Chemotherapy - Highlights from Recent Phase III Studies Genitourinary cancers
01 Oct 2013 ESMO @ ECC 2013: Addition of Trebananib to Paclitaxel Significantly Increases Progression-free Survival in Women with Recurrent Epithelial Ovarian Cancer Gynaecologic malignancies
01 Oct 2013 ESMO @ ECC 2013: Primary Endpoint Unmet in a Phase III Trial of First-Line Treatment with Palifosfamide plus Doxorubicin in Patients with Metastatic Soft Tissue Sarcoma Sarcomas
30 Sep 2013 ECC Press Release: The State of Oncology 2013 – New Report Draws Attention to Urgent Need to Tackle Disparities in Cancer Care Worldwide Bioethics, legal and economic issues
30 Sep 2013 ESMO @ ECC 2013: Cediranib Shows Benefit in Women with Relapsed, Platinum-Sensitive Ovarian Cancer (ICON6) Gynaecologic malignancies
30 Sep 2013 ESMO @ ECC 2013: No Benefit Seen from Adding Zalutumumab to Radiotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck Head and neck cancers
30 Sep 2013 ESMO @ ECC 2013: Targeted Treatment Options May Arise from Molecular Profiling of Patients with Cancers of Unknown Primary Site Carcinoma of unknown primary site
25 Sep 2013 Primary Breast Cancer During Pregnancy: Does it Affect Outcome? Breast cancer
17 Sep 2013 ESMO Press Release: ESMO announces new Editor-in-Chief of Annals of Oncology